MANTOVANI, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 3224
EU - Europa 472
AF - Africa 187
AS - Asia 61
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 3959
Nazione #
US - Stati Uniti d'America 3202
IT - Italia 188
NG - Nigeria 187
FR - Francia 101
NL - Olanda 50
BE - Belgio 39
GB - Regno Unito 35
DE - Germania 28
CA - Canada 21
IL - Israele 13
IN - India 12
TR - Turchia 11
FI - Finlandia 10
CL - Cile 9
CN - Cina 9
RU - Federazione Russa 7
EU - Europa 4
BD - Bangladesh 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
JP - Giappone 2
KR - Corea 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
HK - Hong Kong 1
HR - Croazia 1
IR - Iran 1
MN - Mongolia 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
Totale 3959
Città #
Chandler 907
Wilmington 838
Ann Arbor 286
San Mateo 266
Benin City 187
Lawrence 164
Princeton 164
Leawood 146
Paris 98
Woodbridge 79
Fairfield 71
Boardman 59
Milan 57
Amsterdam 48
Abbiategrasso 39
Brussels 38
Norwalk 29
London 26
Seattle 20
Andover 16
Toronto 15
Falls Church 13
Redmond 13
San Diego 12
Kocaeli 11
Helsinki 10
Redwood City 9
Hanover 7
Pavia 7
Rome 7
Winnipeg 6
Beijing 5
Clearwater 5
Houston 5
Des Moines 4
Borås 3
Caserta 3
Las Vegas 3
Palo Alto 3
Pisa 3
Augusta 2
Collepasso 2
Henderson 2
Leiden 2
Macherio 2
Monmouth Junction 2
Mumbai 2
Phoenix 2
Raleigh 2
Sacramento 2
Ashburn 1
Bari 1
Berlin 1
Bratislava 1
Buffalo 1
Cagayan de Oro 1
Camparada 1
Central District 1
Como 1
Cupertino 1
Dallas 1
Frankfurt am Main 1
Fribourg 1
Garbagnate Milanese 1
Guangzhou 1
Gunzenhausen 1
Irving 1
Izhevsk 1
Kemerovo 1
Leighton Buzzard 1
Leipzig 1
Manchester 1
Melbourne 1
Nanjing 1
Novokuznetsk 1
Piossasco 1
Saint Paul 1
Selangor 1
Shirala 1
Sofia 1
Tirupur 1
Tokyo 1
Tula 1
Ulaanbaatar 1
Vienna 1
Yerevan 1
Zhengzhou 1
Totale 3739
Nome #
Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppression 99
Pentraxins in the activation and regulation of innate immunity 55
Occurrence and significance of tumor - Associated neutrophils in patients with colorectal cancer 48
Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors 48
Combined low densities of FoxP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression 45
Presence of twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors 43
The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling 42
Tumor-associated macrophages and response to 5-flourouracil adjuvant therapy in stage III colorectal cancer 42
The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma 41
Interplay between Myeloid Cells and Humoral Innate Immunity 41
Characterization of MEC 14.7, a new monoclonal antibody recognizing mouse CD34: a useful reage for identifying and characterizing blood vessels and hematopoietic precursors. 40
Morphology of tumour-associated macrophages dictates the prognosis of patients with colorectal liver metastases 39
Evolution of the pentraxin family: the new entry PTX4. 39
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade 39
IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity 38
Macrophage diversity and polarization in atherosclerosis: a question of balance. 37
IL-1 and IL-1 regulatory pathways in cancer progression and therapy 37
Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation 37
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 37
Lack of IL-1R8 in neurons causes hyperactivation of IL-1 receptor pathway and induces MECP2-dependent synaptic defects. 37
Neutrophil diversity and plasticity in tumour progression and therapy 37
Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. 36
Innate immunity, inflammation and tumour progression: double-edged swords 36
Fluid phase recognition molecules in neutrophil-dependent immune responses 36
Regulation of leukocyte recruitment by the long pentraxin PTX3. 36
ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy 36
The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease 35
The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling. 35
CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis : a longitudinal study 35
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis 35
Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells. 34
Chemokines and chemokine receptors in the regulation of dendritic cell trafficking 34
Tumor associated macrophages and neutrophils in tumor progression. 33
Nonredundant role of CCRL2 in lung dendritic cell trafficking. 33
Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. 32
Inflammation-mediated promotion of invasion and metastasis. 32
Anti-tumor activity of cytokines against opportunistic vascular tumors in mice. 32
Cigarette smoke induces PTX3 expression in pulmonary veins of mice in an IL-1 dependent manner. 32
Cytokine regulation of endothelial cells 32
Molecular pathways and targets in cancer-related inflammation. 31
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. 31
Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. 31
Pentraxin 3 regulates synaptic function by inducing AMPA receptor clustering via ECM remodeling and beta 1-integrin 31
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. 31
Anti-human migration stimulating factor (msf) and uses thereof 31
Toll-like receptor signaling and SIGIRR in renal fibrosis upon unilateral ureteral obstruction. 30
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients. 30
Novel pathways for negative regulation of inflammatory cytokines centered on receptor expression. 30
Chorionic gonadotropin up-regulates long pentraxin 3 expression in myeloid cells. 29
AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients 29
Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. 29
Damping Excessive Inflammation and Tissue Damage in Mycobacterium tuberculosis Infection by Toll IL-1 Receptor 8/Single Ig IL-1-Related Receptor, a Negative Regulator of IL-1/TLR Signaling 29
Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. 28
A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. 28
PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. 28
Implication of the oligomeric state of the N-terminal PTX3 domain in cumulus matrix assembly 28
An integrated view of humoral innate immunity: pentraxins as a paradigm. 28
Pentraxins in innate immunity: lessons from PTX3. 27
The expression pattern of TIR8 is conserved among vertebrates. 27
Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens. 27
PTX3 as a paradigm for the interaction of pentraxins with the Complement system 27
The Long Pentraxin PTX3 as a Link Among Innate Immunity, Inflammation, and Female Fertility 27
Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis 27
Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation 27
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 27
Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm. 27
Pentraxins as a key component of innate immunity. 26
Pentraxins and atherosclerosis: the role of PTX3. 26
The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. 26
Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients 26
Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptor-related protein. 26
The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice. 26
Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6 26
Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction. 26
Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. 26
Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma. 25
Tumor associated macrophages and neutrophils in cancer 25
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer 25
ERK-dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in Kaposi sarcoma. 25
Pentraxins: multifunctional proteins at the interface of innate immunity and inflammation. 25
Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis. 25
Follicular fluid levels of the long pentraxin PTX3. 25
Control of Complement Activation by the Long Pentraxin PTX3: Implications in Age-Related Macular Degeneration 25
Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis. 24
PTX3 predicts severe disease in febrile patients at the emergency department. 24
Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation. 24
Dynamic induction of the long pentraxin PTX3 in CNS after limbic seizures: evidence for a protective role in seizure-induced neurodegeneration 24
The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. 24
The Long Pentraxin PTX3 in Bone Homeostasis and Pathology 24
Regulatory Role of IL-1R8 in immunity and Disease 24
SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis. 24
Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus. 24
Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. 24
Coregulation in human leukocytes of the long pentraxin PTX3 and TSG-6. 24
Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity. 23
Myosin vb mobilizes the decoy receptor D6 from recycling endosome for adaptive up-regulation and chemokine degradation 23
PTX3 expression in the heart tissues of patients with myocardial infarction and infectious myocarditis. 23
IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8. 23
Different roles of TiR8/Sigirr on toll-like receptor signaling in intrarenal antigen-presenting cells and tubular epithelial cells. 23
Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. 23
Totale 3146
Categoria #
all - tutte 21444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0000 00 00 0009
2020/20211685 23191116 9554 301106 32116716142
2021/2022952 222115163 2120 43113 14211218694
2022/20231555 373122244327 263215 110 0000
Totale 4201